Company Profile

Cellomics Inc
Profile last edited on: 11/6/2015      CAGE:       UEI:

Business Identifier: High content screening systems for drug screening and localization within living cells
Year Founded
----
First Award
1996
Latest Award
1999
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

635 William Pitt Way
Pittsburgh, PA 15238
   N/A
   N/A
   N/A
Location: Single
Congr. District: 17
County: Allegheny

Public Profile

In August 2005, Cellomics Inc was acquired by Fisher Scientific International Inc for $49 Million. Cellomics Inc, formerly known as BioDx Inc, is developing and commercializing products in the field of cellomics to extend the advances in genomics and proteomics. The firm is engaging in the development of an integrated product platform, including high content screening products to measure the physical position and activity over time of cells and cellular components. The company integrates fluorescent reagents, kits, cell lines, multiparametric assays, informatics, cell analysis instrumentation, and cellular bioinformatics tools to achieve an applicable platform for users in the pharmaceutical industry.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
50-74

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1999 1 NIH $200,000
Project Title: Automatic Systems For Aneuploidy Detection In Sperm
1996 1 NIH $50,000
Project Title: Automated System For Aneuploidy Detection In Sperm

Key People / Management

  Terry R Dunlay

Company News